Advertisement
CHE vs PNTG
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CHE is a Buy and PNTG is a Hold.
Momentum Indicator for CHE turns positive, indicating new upward trend
CHE saw its Momentum Indicator move above the 0 level on October 20, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 91 similar instances where the indicator turned positive. In 55 of the 91 cases, the stock moved higher in the following days. The odds of a move higher are at 60%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Moving Average Convergence Divergence (MACD) for CHE just turned positive on October 14, 2026. Looking at past instances where CHE's MACD turned positive, the stock continued to rise in 27 of 51 cases over the following month. The odds of a continued upward trend are 53%.
CHE moved above its 50-day moving average on October 28, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for CHE crossed bullishly above the 50-day moving average on October 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 7 of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 50%.
Following a +6.45% 3-day Advance, the price is estimated to grow further. Considering data from situations where CHE advanced for three days, in 159 of 322 cases, the price rose further within the following month. The odds of a continued upward trend are 49%.
The Aroon Indicator entered an Uptrend today. In 76 of 200 cases where CHE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 38%.
Bearish Trend Analysis
The 10-day RSI Indicator for CHE moved out of overbought territory on October 30, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In 28 of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at 68%.
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 33 of 69 cases where CHE's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 48%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.
CHE broke above its upper Bollinger Band on October 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 28 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 36 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is 43 (best 1 - 100 worst), indicating steady price growth. CHE’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Profit vs. Risk Rating rating for this company is 67 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CHE’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock better than average.
The Tickeron Valuation Rating of 78 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (8.400) is normal, around the industry mean (204.059). P/E Ratio (26.836) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (1.876) is also within normal values, averaging (2.498). Dividend Yield (0.005) settles around the average of (0.091) among similar stocks. P/S Ratio (2.714) is also within normal values, averaging (2.688).
PNTG's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for PNTG turned positive on November 04, 2026. Looking at past instances where PNTG's MACD turned positive, the stock continued to rise in 43 of 52 cases over the following month. The odds of a continued upward trend are 83%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 63 cases where PNTG's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on PNTG as a result. In 69 of 92 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 75%.
PNTG moved above its 50-day moving average on October 05, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +8.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where PNTG advanced for three days, in 244 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 78%.
The Aroon Indicator entered an Uptrend today. In 183 of 236 cases where PNTG Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 78%.
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PNTG declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
PNTG broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 12 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. PNTG’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 44 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock slightly better than average.
The Tickeron SMR rating for this company is 72 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.890) is normal, around the industry mean (204.059). P/E Ratio (42.553) is within average values for comparable stocks, (18.581). Projected Growth (PEG Ratio) (2.017) is also within normal values, averaging (2.498). Dividend Yield (0.000) settles around the average of (0.091) among similar stocks. P/S Ratio (1.373) is also within normal values, averaging (2.688).
CHE | PNTG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 23 | 18 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 78 Overvalued | 87 Overvalued | |
PROFIT vs RISK RATING 1..100 | 67 | 44 | |
SMR RATING 1..100 | 36 | 72 | |
PRICE GROWTH RATING 1..100 | 43 | 40 | |
P/E GROWTH RATING 1..100 | 28 | 12 | |
SEASONALITY SCORE 1..100 | 50 | 35 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
CHE's Valuation (78) in the Medical Or Nursing Services industry is in the same range as PNTG (87) in the null industry. This means that CHE’s stock grew similarly to PNTG’s over the last 12 months.
PNTG's Profit vs Risk Rating (44) in the null industry is in the same range as CHE (67) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew similarly to CHE’s over the last 12 months.
CHE's SMR Rating (36) in the Medical Or Nursing Services industry is somewhat better than the same rating for PNTG (72) in the null industry. This means that CHE’s stock grew somewhat faster than PNTG’s over the last 12 months.
PNTG's Price Growth Rating (40) in the null industry is in the same range as CHE (43) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew similarly to CHE’s over the last 12 months.
PNTG's P/E Growth Rating (12) in the null industry is in the same range as CHE (28) in the Medical Or Nursing Services industry. This means that PNTG’s stock grew similarly to CHE’s over the last 12 months.
| CHE | PNTG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 68% | N/A |
| Stochastic ODDS (%) | 2 days ago 48% | 2 days ago 78% |
| Momentum ODDS (%) | 2 days ago 60% | 2 days ago 75% |
| MACD ODDS (%) | 2 days ago 53% | 2 days ago 83% |
| TrendWeek ODDS (%) | 2 days ago 52% | 2 days ago 79% |
| TrendMonth ODDS (%) | 2 days ago 52% | 2 days ago 79% |
| Advances ODDS (%) | 8 days ago 49% | 2 days ago 78% |
| Declines ODDS (%) | 10 days ago 49% | 4 days ago 72% |
| BollingerBands ODDS (%) | 2 days ago 52% | 2 days ago 67% |
| Aroon ODDS (%) | 2 days ago 38% | 2 days ago 78% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CHE’s FA Score shows that 1 FA rating(s) are green while PNTG’s FA Score has 1 green FA rating(s).
- CHE’s FA Score: 1 green, 4 red.
- PNTG’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CHE’s TA Score shows that 6 TA indicator(s) are bullish while PNTG’s TA Score has 6 bullish TA indicator(s).
- CHE’s TA Score: 6 bullish, 4 bearish.
- PNTG’s TA Score: 6 bullish, 2 bearish.
Price Growth
CHE (@Hospital/Nursing Management) experienced а +2.86% price change this week, while PNTG (@Hospital/Nursing Management) price change was +4.46% for the same time period.
The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was -0.14%. For the same industry, the average monthly price growth was +5.08%, and the average quarterly price growth was +15.61%.
Reported Earning Dates
CHE is expected to report earnings on Feb 25, 2027.
PNTG is expected to report earnings on Mar 03, 2027.
Industries' Descriptions
@Hospital/Nursing Management (-0.14% weekly)Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.
Advertisement
PNTG and
Correlation & Price change
A.I.dvisor indicates that over the last year, PNTG has been loosely correlated with UHS. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if PNTG jumps, then UHS could also see price increases.
| Ticker / NAME | Correlation To PNTG | 1D Price Change % | ||
|---|---|---|---|---|
| PNTG | 100% | +6.92% | ||
| UHS - PNTG | 42% Loosely correlated | +10.91% | ||
| ENSG - PNTG | 42% Loosely correlated | +3.35% | ||
| AVAH - PNTG | 41% Loosely correlated | +7.15% | ||
| ADUS - PNTG | 41% Loosely correlated | +1.10% | ||
| CON - PNTG | 40% Loosely correlated | +8.49% | ||
More | ||||